Synergistic interactions of cyclosporine, rapamycin, and brequinar on heart allograft survival in mice.
Stepkowski
S M
SM
Department of Surgery, University of Texas Medical School at Houston 77030.
Tu
Y
Y
Chou
T C
TC
Kahan
B D
BD
D000818:Animals; D001713:Biphenyl Compounds / Q000627:therapeutic use*; D016572:Cyclosporine / Q000627:therapeutic use*; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D005260:Female; D006085:Graft Survival / Q000187:drug effects*; D016027:Heart Transplantation / Q000276:immunology*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D051379:Mice; D008807:Mice, Inbred BALB C; D008809:Mice, Inbred C3H; D008810:Mice, Inbred C57BL; D011090:Polyenes / Q000627:therapeutic use*; D020123:Sirolimus; D014184:Transplantation, Homologous; D011798:Quinaldines
D001713:Biphenyl Compounds; D016572:Cyclosporine; D007166:Immunosuppressive Agents; D011090:Polyenes; D020123:Sirolimus; C046943:brequinar; D011798:Quinaldines